Latest news

Thumbnail image for Wales backs NHS use of Actelion’s Uptravi for PAH

Wales backs NHS use of Actelion’s Uptravi for PAH

Some patients with pulmonary arterial hypertension (PAH) are now able to access Actelion’s selexipag on the NHS in Wales after a green light from the All Wales Medicines Strategy Group (AWMSG).

14th June 2018

Thumbnail image for Final NICE nod for Janssen’s Tremfya

Final NICE nod for Janssen’s Tremfya

The National Institute for Health and Care Excellence (NICE) has now issued guidance recommending Janssen’s Tremfya as an option for treating plaque psoriasis in adults on the NHS.

14th June 2018

Thumbnail image for ViiV’s two-drug HIV regimen hits PhIII targets

ViiV’s two-drug HIV regimen hits PhIII targets

ViiV Healthcare’s two-drug HIV regimen of Tivicay and Epivir has hit targets in late-stage trials, showing non-inferiority to a three-drug regimen and thus the potential to offer patients an alternative treatment strategy.

14th June 2018

Thumbnail image for Public backs NHS spending increases

Public backs NHS spending increases

An “overwhelming majority” of people support increasing spending on health and social care services, indicates a poll of 1,000 adults across Britain undertaken by Ipsos Mori for the NHS Confederation.

13th June 2018

Thumbnail image for SMC approves funding for six new therapies on the NHS

SMC approves funding for six new therapies on the NHS

The Scottish Medicines Consortium has approved NHS funding for six new therapies, offering patients new options for leukaemia, epilepsy, lung cancer, plaque psoriasis, and carcinoid syndrome-related diarrhea.

12th June 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download